ESC 365 - Use of P2Y12 inhibitors in acute coronary syndromes.

ESC Premium Access

Use of P2Y12 inhibitors in acute coronary syndromes.

Session: APSC Consensus Statements session

Topic: European Society of Cardiology

Speaker: Associate Professor J. Tan (Singapore, SG)

Event: ESC Asia with APSC & AFC 2021

Presentation

About the speaker

Associate Professor Jack Wei Chieh Tan

National Heart Centre Singapore, Singapore (Singapore)

14 presentations

2 followers

5 more presentations in this session

Use of P2Y12 inhibitors in acute coronary syndromes - panel discussion.

Use of DOACs in atrial fibrillation.

Speaker: Doctor D. Chong (Singapore, SG)

Use of DOACs in atrial fibrillation - panel discussion.

Use of Mitraclip.

Speaker: Associate Professor K. Yeo (Singapore, SG)

Use of Mitraclip - panel discussion.

Access the full session

APSC Consensus Statements session

Speakers: Associate Professor J. Tan, Doctor D. Chong, Associate Professor K. Yeo

About the event

ESC Asia with APSC & AFC 2021

2 December - 4 December 2021

Sessions Presentations

Congress

Related content

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

Open Access

Unlocking the value of device data for better remote HF management.

22 October 2021

ESC Premium Access

Best of EHJ Digital Health - Editors’ choice - Interview

22 October 2021

This platform is supported by